Navigation Links
PAR in Medical News

Thomas P. Rice Elected to Board of Directors of Par Pharmaceutical Companies, Inc.

WOODCLIFF LAKE, N.J., June 12 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX ) today announced that Thomas P. Rice has been elected to the company's board of directors. Mr. Rice was also appointed to the Audit Committee and the Nominating-Corporate Governance Committee....

Stay on Par this Golf Season, Injury Free

Orthopaedic surgeons offer tips to minimize golf-related injuries ROSEMONT, Ill., May 19 /PRNewswire-USNewswire/ -- Swinging the club on the open green, hitting the perfect shot and playing in the warm sun are just a few things golfers love about hitting the links. Golfing can be a treat ...

Federal Trade Commission Files Complaint Against Par Pharmaceutical Over Court-Approved AndroGel(R) Litigation Settlement

WOODCLIFF LAKE, N.J., Feb. 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX ) today announced that it learned after the close of business on Friday, January 30, 2009 that the Federal Trade Commission and the California Attorney General filed a lawsuit against Par in the ...

MonoSol Rx Licenses Thin Film Formulation of Ondansetron to Strativa Pharmaceuticals, a Division of Par Pharmaceutical

MonoSol Rx to initiate pivotal trials for ondansetron thin film immediately WARREN, N.J. and PORTAGE, Ind., June 17 /PRNewswire/ -- MonoSol Rx, a drug delivery company specializing in dissolving thin film pharmaceutical products, and Strativa Pharmaceuticals, the proprietary products division of...

Nurturing Our Nurses for Healthcare Par Excellence

'Nurses - one of the few blessings of being ill' - Sara Moss-Wolfe Nobility, thy name is Nursing Care, comfort, and compassion are traits sacrosanct to the nursing profession , just as dedication and patience are its greatest virtues. It might seem implausible to visualize these att...

Dogs Reasoning on Par With Human Toddlers: Study

They are mans best friends, and now dogs have surprised researchers by showing that they are capable of advanced reasoning as much as human toddlers. The study, by Austrian researchers, shows that dogs behaviour is pretty sophisticated when it comes to a physical problem-solving test. ...

Blacks Get Treatment on Par With Whites for Cardiovascular Disease

Health outcomes for blacks with cardiovascular disease are similar or better than those of whites when differences in access and treatment are minimized, according to a study// published in the American Heart Journal, Reuters reports. For the study, Nancy Kressin of the Edith Nourse Rogers M...

India On Par with South Africa in AIDS Count

Recent survey conducted by UNAIDS has put India on par with South Africa. It has been revealed that these two countries have the highest estimated number of HIV infected people//. The number of people living with HIV according to the UNAIDS 2006 Report on the Global AIDS Epidemic is 5.7 million...

Elders Too Are Keen To Chat On Internet On Par With Youngsters

According to a recent online survey, aging in no way deter the elders from chatting or surfing the Internet and said that they too are keen in using the net on par// with the youngsters. The survey conducted by the Internet and Mobile Association of India with Crosstab Marketing Services has r...

Labopharm Reports Results for Second Quarter Fiscal 2009

...--------------------------------------------------------------------- Shareholders' equity (deficiency) Share capital Common shares, no par value, unlimited authorized shares, 57,000,533 and 56,826,063 issued as at June 30, 2009 and December 31, 2008, respectively ...

More>>

PAR in Medical Technology

Spherix Reports First Quarter 2009 Earnings

...ockholders' equity Preferred stock, $0.01 par value, 2,000,000 shares authorized; ... - - Common stock, $0.005 par value, 50,000,000 shares authorized; ... 72,188 Paid-in capital in excess of par value 27,610,426 27,602,486 Treasury s...

Bionovo Announces First Quarter 2009 Highlights and Financial Results

...d contingencies Shareholders' equity: Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued and outs...ding - - Common stock $0.0001 par value, 190,000,000 shares authorized, 76,363,101 and 76,3...

Strativa Pharmaceuticals Provides Product Pipeline Update

... products division of a wholly owned subsidiary of par Pharmaceutical Companies, Inc. (NYSE: PRX ), tod...aceuticals is the proprietary products division of par Pharmaceutical, Inc. Strativa is committed to deve...ease visit www.strativapharma.com . About par Pharmaceutical ...

Elbow Ligament Reconstruction Appears Not to Affect Future Professional Advancement in Baseball

...it is heartening to see that the procedure can be successful in allowing future professional athletes to the reach the highest level of competition on par with their peers," said Carolan. The American Orthopaedic Society for Sports Medicine (AOSSM) is a world leader in sports medicine education, res...

Pharmasset Reports Fiscal Year End 2008 Financial Results

...bilities 33,794,724 16,908,073 COMMITMENTS & CONTINGENCIES STOCKHOLDERS' EQUITY Common Stock, $0.001 par value, 100,000,000 shares authorized, 23,340,498 and 21,232,991 shares issued and outstanding at September 30,...

Alfacell Provides ONCONASE(R) NDA Submission Update

...iple molecular mechanisms of action. Alfacell has licensed the U.S. commercial rights for ONCONASE to Strativa Pharmaceuticals, a division of par Pharmaceutical, Inc. Strategic marketing and distribution agreements for ONCONASE have been secured with Megapharm Ltd. for Israel, BL&H Co. Ltd....

SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results

...ckholders' Equity Preferred stock, authorized 5,000,000 shares, $.01 par value, none issued or outstanding - - Common stock, authorized 100,000,000 shares, $.001 par value, 41,130,270 and 40,991,385 issued and outstanding as of Septe...

FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A

...FS is an effective prophylactic FVIII replacement product has 'jump started' the standard of hemophilia care in the United States so that it is now on par with other developed countries, especially those in Western and Northern Europe." The FDA approval of Kogenate(R) FS for routine prophylaxis in chil...

Pharmasset Reports Financial Results for Quarter Ended June 30, 2008

...45 16,908,073 -------------------------- COMMITMENTS STOCKHOLDERS' EQUITY Common Stock, $0.001 par value, 100,000,000 shares authorized, 21,751,503 and 21,232,991 shares issued and outstanding at June 30, 2008 (unaudited) and September 30, 200...

MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Product Development

...uding the recently announced licensing of our thin film formulation of ondansetron, an anti-emetic therapy, to Strativa Pharmaceuticals, a division of par Pharmaceuticals. Our expectation is to partner our PharmFilm(R) escitalopram oxalate product with a pharmaceutical company that is competitively posit...

More>>

PAR in Biological News

Hypertension among lower-status employees lingers well into retirement

... be an additional 2.1 million people in the United States with job-related hypertension. Leigh hopes that this study will help bring job history on par with lifestyle factors when physicians consider hypertension risks with their patients. "Even among the obese, we found that occupation correlated ...

Exhibition showcases the 'art of science'

...spired by science. "This show exuberantly supports the idea that images produced in the pursuit of science can have an aesthetic value that is on a par with art created for art's sake," said Andrew Zwicker, the head of Science Education at the Princeton Plasma Physics Laboratory (PPPL) and a lecturer ...

Difference in fat storage may explain lower rate of liver disease in African-Americans

...o be based on gender. Caucasian males are at the highest risk for NAFLD, on par with the risk faced by Hispanics in general. Caucasian females are on par with the African-American population, at about 23 percent. Caucasian female...

Cellulosic biofuel technology will generate low-cost green fuel, says major study

... technology." The researchers also found that the mature cellulosic biofuel technologies analysed: Have the potential to realise efficiencies on par with petroleum-based fuels. Require modest volumes of process water. Achieve production costs consistent with gasoline when oil prices are at about ...

Beckman Coulter Updates 2008 Outlook

...mpany estimates that, based on current exchange rates, full year 2008 revenue should increase by about 12%. Operating margins are anticipated to be on par with prior year results, between 11.5% and 12%. Non operating expense should be about $48 million. Therefore, earnings per share expectations remain...

UAF researchers to present at AGU press briefing

...emical and geophysical measurement techniques, a first in the area. He also noted that while the high-arctic ocean readings were surprisingly high, on par with those from high-arctic lakes, they are still much lower than is being found in subarctic regions. "That means we cannot extrapolate the subarc...

Study rules out inbreeding as cause of amphibian deformities

...missing, extra or dwarfed digits (equivalent to fingers and toes). That is double the rate of malformation found in newts, a related amphibian, but on par and with frequencies seen in many frog species, said assistant professor of forestry and natural resources Rod Williams. "This is really the first ...

Synaptics Reports Record Results for First Quarter of Fiscal 2009

...and contingencies Stockholders' equity: Preferred stock; $.001 par value; 10,000,000 shares authorized; no shares issued and ... - - Common stock; $.001 par value; 60,000,000 shares authorized; 42,835,461 and 42,500,...

Geologist who linked cosmic strike to dinosaurs' extinction takes top prize

...er, World War II military leader and pioneer in transatlantic air travel. Vetlesen passed away in 1955. Designed to recognize sweeping achievements on par with the Nobel (which has no regular prize in earth sciences) it is given every several years by a jury appointed by the president of Columbia Univers...

Oceans on the precipice: Scripps scientist warns of mass extinctions and 'rise of slime'

...ngs of the National Academy of Sciences ( PNAS ), Jackson believes that human impacts are laying the groundwork for mass extinctions in the oceans on par with vast ecological upheavals of the past. He cites the synergistic effects of habitat destruction, overfishing, ocean warming, increased acidific...

More>>

PAR in Biological Technology

Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine

WOODCLIFF LAKE, N.J., Feb. 25 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX ) today announced that its development partner, Immtech Pharmaceuticals, Inc. (Amex: IMM ) has cho...

Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products

Pafuramidine on Clinical Hold Loramyc(R) Completes Patient Enrollment Ahead of Schedule Zensana(TM) Reformulation Complete, Resubmission on Target WOODCLIFF LAKE, N.J., Dec. 28 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX ) today pro...

Novavax Reports Second Quarter 2009 Financial Results

...compared to $33.9 million as of December 31, 2008. The company's short-term investments consist of investments in five auction rate securities with a par value of $8.1 million and a fair value of $6.0 million. In addition to the other than temporary impairment discussed above, during the second quarter ...

American Oriental Bioengineering Reports Second Quarter 2009 Financial Results

...OMMITMENTS EQUITY SHAREHOLDERS' EQUITY Preferred stock, $0.001 par value; 2,000,000 shares authorized; 1,000,000 shares issued and ...pectively 1,000 1,000 Common stock, $0.001 par value; 150,000,000 shares authorized; 78,301,439 and 78,249,264 s...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... 275.0 291.3 Total liabilities 2,652.2 2,635.2 Shareholders' equity: Common stock of 5p par value; 1,000 million shares authorized; and 560.3 million shares issued and outstanding (2008: 1,000 million shares authorized; and 560.2 ...

NxStage Reports Second Quarter 2009 Financial Results

...ingencies Stockholders' equity: Undesignated preferred stock: par value $0.001, 5,000,000 shares authorized; no shares issu...December 31, 2008 - - Common stock: par value $0.001, 100,000,000 shares authorized; 46,658,515 and ...

ERT Reports Second Quarter 2009 Results

...------ ------ Stockholders' equity: Preferred stock-$10.00 par value, 500,000 shares authorized, none issued and outstanding... - - Common stock-$.01 par value, 175,000,000 shares authorized, 59,950,257 and 59,985,4...

Sigma-Aldrich (Nasdaq:SIAL) Reports Q2 2009 Diluted EPS of $0.68; YTD Diluted EPS up 1.5% to $1.36. Full Year 2009 Guidance Reaffirmed, With 2009 Diluted EPS Expected to Exceed 2008's $2.65.

...------- ------- Stockholders' equity: Common stock 201.8 201.8 Capital in excess of par value 137.8 133.0 Common stock in treasury (1,953.5) (1,935.3) Retained earnings ...

Essilor : First Half 2009 Revenue

...targeted acquisitions dynamic. In light of these factors, Essilor is confident in its ability to maintain first-half 2009 operating margin on a par with full-year 2008. Consolidated revenue for the first six months of 2009 EUR millions H1 2009 H1 2008 % Change % Change Con...

Vasogen Announces Second Quarter 2009 Results

... 1,288 1,242 Shareholders' equity: Share capital: Authorized: Unlimited common shares, without par value Issued and outstanding: 22,623,195 common shares (November 30, 2008 - 22,424,719) 365,730 365,677 ...

More>>

Other Tags
(Date:7/12/2014)... 12, 2014 Wright & Schulte LLC has ... , Inc., a subsidiary of Johnson & Johnson, on behalf ... pain after receiving a metal-on-metal DePuy Pinnacle hip replacement and ... the artificial hip implant. The DePuy hip lawsuit was filed ... of Texas (Case No. 3:14-cv-2427) where DePuy Pinnacle Hip ...
(Date:7/12/2014)... City, Utah (PRWEB) July 12, 2014 ... two types of startups, with awards being bestowed to ... emphasis spotlighted Utah’s outstanding entrepreneur community with recognition for ... a sustainable model with incoming revenue. , 25 Under ... across the state that are under 5 years old. ...
(Date:7/12/2014)... 12, 2014 Wright & Schulte LLC, an ... Just For Men Lawsuits (case #59776/2014), announces they have ... reports that allege the popular hair dye, Just For Men, ... their face, neck and other areas. In addition to detailing ... chemical burns , the advertisements being run by Wright & ...
(Date:7/12/2014)... The largest pure occupational medicine company in ... that it will be opening its fifth Georgia center ... four Atlanta-based Nova Medical Centers’ locations. The Augusta ... Road, and will be open from 8:30 a.m. to ... treatment philosophy of rapid return-to-work and decreased treatment times ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 The American ... America’s 55 poison centers are commending Senator Bill Nelson ... Prevention Act of 2014 on July 10, 2014. Along ... Consumer Products Safety Commission (CPSC) to enact rules requiring ... consumers. , Senate co-sponsors of the bill ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 5Health News:SquareHook is Recognized for UVEF 25 Businesses Under 5 Years-Watch Out 2Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 2Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 3Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 4Health News:Nova Medical Centers To Open New Facility in Augusta, Georgia 2Health News:AAPCC Issues Statement on the Introduction of the Child Nicotine Poison Prevention Act of 2014 2Health News:AAPCC Issues Statement on the Introduction of the Child Nicotine Poison Prevention Act of 2014 3
(Date:7/11/2014)... Bone and Mineral Research awarded Michael F. Holick, PhD, ... the 2014 Louis V. Avioli Award. Holick, a professor ... known for revolutionizing the understanding of vitamin D and ... honors a member of the American Society for Bone ... and mineral basic research. It is named for ASBMR,s ...
(Date:7/11/2014)... set a "mouse TRAP" to capture the early signs ... published in the Journal of Clinical Investigation . ... TRAP to extract cellular and genetic information from a ... the Rockefeller Institute for Medical Research in 2008, TRAP ... or ribosomes, of the cell type of interest. Scientists ...
(Date:7/11/2014)... China Researchers from Salk Institute for Biological Studies, ... evaluated the safety and reliability of the existing ... new method, TALEN-HDAdV, which could significantly increased gene-correction ... This study published online in Cell Stell ... stem cell-based gene therapy. , The combination of ...
Breaking Biology News(10 mins):BUSM's Michael F. Holick receives American Society for Bone and Mineral Research award 2A new genome editing method brings the possibility of gene therapies closer to reality 2
Other Contents